In Sudan’s White Nile State, the reopening of schools is helping displaced and local communities recover from conflict and ...
The Centers for Disease Control and Prevention announced updates to its recommendations for childhood vaccines. Here's what ...
Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results